Aclaris to Present at 35th Annual J.P. Morgan Healthcare Conference

January 3, 2017

MALVERN, Pa., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led clinical-stage pharmaceutical company focused on defining new standards of care in medical and aesthetic dermatology, today announced that it plans to present at the 35th Annual J.P. Morgan Healthcare Conference. Aclaris President and Chief Executive Officer Dr. Neal Walker will present on Wednesday, January 11, 2016 at 3:30 pm PT (6:30 pm ET) at The Westin St. Francis in San Francisco.

A live audio webcast of the presentation will be available on the Investors section of the company's website, www.aclaristx.com. A replay will be available after the event.

About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania.

Contact:

Aclaris Contact
Michael Tung, M.D.
Investor Relations
484-329-2140
mtung@aclaristx.com

Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com

Aclaris Therapeutics, Inc.

Press Release